Nelarabine Injection
Product Images NDC 70771-1685

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 70771-1685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (3fdea8e8 07e5 41bc 964d 34b7a82e24f1 01)

Nelarabine Injection label showing 250 mg/50 mL (5 mg/mL) strength for intravenous infusion. The label states it is a 50 mL single-dose vial from Zydus Pharmaceuticals, distributed by Zydus Lifesciences Limited. The label includes storage instructions, excipient information, and notes for discard of unused portion. It also indicates no preservatives, latex-free vial stoppers, and manufacturing by Cadila Healthcare Ltd., India.*

FDA Label Image

1's Carton (3fdea8e8 07e5 41bc 964d 34b7a82e24f1 02)

Nelarabine Injection 250 mg/50 mL (5 mg/mL) single-dose vial packaging label by Zydus Lifesciences Limited. The label specifies intravenous infusion use only and instructions to discard unused portions. It includes storage information, absence of preservatives, and a warning about the vial stopper material, along with manufacturer details, barcode, and NDC 70771-1685-1.*

FDA Label Image

6's Carton (3fdea8e8 07e5 41bc 964d 34b7a82e24f1 03)

Packaging label for Nelarabine Injection 250 mg/50 mL (5 mg/mL) for intravenous infusion. The label indicates six 50 mL single-dose vials per carton. The product is labeled by Zydus Lifesciences Limited with NDC 70771-1685. The carton includes storage instructions and a barcode. It notes the disposal of unused portions and product specifications.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.